Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo. [electronic resource]
Producer: 20151026Description: 1913-22 p. digitalISSN:- 1791-2431
- ADAM Proteins -- genetics
- ADAM10 Protein
- Amyloid Precursor Protein Secretases -- genetics
- Animals
- Apoptosis
- Carcinoma, Hepatocellular -- drug therapy
- Cell Proliferation -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Female
- Gene Knockout Techniques
- Genetic Vectors -- administration & dosage
- Hep G2 Cells
- Humans
- In Vitro Techniques
- Liver Neoplasms -- drug therapy
- Membrane Proteins -- genetics
- Mice
- Mice, Inbred BALB C
- Neoplasm Transplantation
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Plasmids -- genetics
- RNA, Small Interfering -- metabolism
- Sorafenib
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.